DK2984175T3 - Dna-guidet dna-interferens ved en prokaryotisk argonaute - Google Patents

Dna-guidet dna-interferens ved en prokaryotisk argonaute Download PDF

Info

Publication number
DK2984175T3
DK2984175T3 DK14800396.5T DK14800396T DK2984175T3 DK 2984175 T3 DK2984175 T3 DK 2984175T3 DK 14800396 T DK14800396 T DK 14800396T DK 2984175 T3 DK2984175 T3 DK 2984175T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
argonaute
aspects
targeting
cell
Prior art date
Application number
DK14800396.5T
Other languages
English (en)
Inventor
Andrew Paul May
Rachel E Haurwitz
Der Oost John Van
Daniël Christianus Swarts
Original Assignee
Caribou Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201306574A external-priority patent/GB201306574D0/en
Application filed by Caribou Biosciences Inc filed Critical Caribou Biosciences Inc
Application granted granted Critical
Publication of DK2984175T3 publication Critical patent/DK2984175T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Claims (16)

1. Fremgangsmåde til spaltning af en dobbeltstrenget nucleinsyre-målsekvens der har en første streng og en anden streng, i en værtscelle, hvilken fremgangsmåde omfatter: at kontakte den dobbeltstrengede nucleinsyre-målsekvens med et første kompleks, der omfatter et første prokaryotisk argonaute-protein og en første guide-nucleinsyre, hvor den første guide-nucleinsyre hybridiserer med den første streng af den dobbeltstrengede nucleinsyre-målsekvens i værtscellen, og det første kompleks spalter den første streng af den dobbeltstrengede nucleinsyre-målsekvens; og et andet kompleks der omfatter et andet prokaryot argonaute-protein og en anden guide-nucleinsyre, hvor den anden guide-nucleinsyre hybridiserer med den anden streng af den dobbeltstrengede nucleinsyre-målsekvens i værtscellen, og det andet kompleks spalter den anden streng af den dobbeltstrengede nucleinsyre målsekvens; hvilken fremgangsmåden ikke er en fremgangsmåde til terapeutisk behandling af et menneske eller dyr krop, og hvor det første og det andet prokaryote argonaute-protein er valgt fra gruppen, der består af et Thermus termophilus argonaute-(TtAgo)-protein eller et Synechococcus elongatus argonaute-(SeAgo)-protein.
2. Fremgangsmåden ifølge krav 1, hvor spaltningen af den dobbeltstrengede nucleinsyre-målsekvens resulterer i et snit med blunt-ende.
3. Fremgangsmåde ifølge krav 1, hvor spaltningen af den dobbeltstrengede nucleinsyre-målsekvens resulterer i et snit med staggeret ende.
4. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 3, hvor den dobbeltstrengede nucleinsyre-målsekvens omfatter DNA.
5. Fremgangsmåde ifølge krav 4, hvor et genomisk DNA i en eukaryot celle omfatter den dobbeltstrengede nucleinsyre-målsekvens.
6. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 3, hvor den dobbeltstrengede nucleinsyre-målsekvens omfatter RNA.
7. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 6, hvor den første guide-nucleinsyre og den anden guide-nucleinsyre omfatter DNA.
8. Fremgangsmåden ifølge krav 7, hvor den første guide-nucleinsyre og den anden guide-nucleinsyre yderligere omfatter RNA.
9. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 6, hvor den første guide-nucleinsyre og den anden guide-nucleinsyre omfatter RNA.
10. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor værtscellen er en eukaryot celle.
11. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor det første prokaryote argonaute-protein og det andet prokaryote argonaute-protein udtrykkes fra en eller flere polynucleotider, som koder for det første prokaryote argonaute-protein og det andet prokaryote argonaute-protein.
12. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor den første guide-nucleinsyre, den anden guide-nucleinsyre eller den første og anden guide-nucleinsyre udtrykkes fra en eller flere polynucleotider, der koder for den første guide-nucleinsyre, den anden guide-nucleinsyre, henholdsvis den første og den anden guide-nucleinsyre.
13. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor kontakten resulterer i en deletion i den dobbeltstrengede nucleinsyre-målsekvens.
14. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor kontakten resulterer i en insertion af mindst en del af et polynucleotid i den dobbeltstrengede nucleinsyre-målsekvens.
15. Fremgangsmåden ifølge krav 14, hvor den dobbeltstrengede nucleinsyre-målsekvens omfatter DNA, den første guide-nucleinsyre omfatter DNA, og den anden guide-nucleinsyre omfatter DNA.
16. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor det første prokaryote argonaute-protein og det andet prokaryote argonaute-protein er det samme protein.
DK14800396.5T 2013-04-11 2014-04-11 Dna-guidet dna-interferens ved en prokaryotisk argonaute DK2984175T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB201306574A GB201306574D0 (en) 2013-04-11 2013-04-11 Use of prokaryotic Argonaute proteins for cleavage of DNA plasmids
US201461939680P 2014-02-13 2014-02-13
US14/250,224 US9902973B2 (en) 2013-04-11 2014-04-10 Methods of modifying a target nucleic acid with an argonaute
PCT/US2014/033885 WO2014189628A1 (en) 2013-04-11 2014-04-11 Dna-guided dna interference by a prokaryotic argonaute

Publications (1)

Publication Number Publication Date
DK2984175T3 true DK2984175T3 (da) 2019-03-04

Family

ID=51933950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14800396.5T DK2984175T3 (da) 2013-04-11 2014-04-11 Dna-guidet dna-interferens ved en prokaryotisk argonaute

Country Status (4)

Country Link
US (2) US9902973B2 (da)
EP (1) EP2984175B1 (da)
DK (1) DK2984175T3 (da)
WO (1) WO2014189628A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2662932C2 (ru) * 2013-03-14 2018-07-31 Карибо Биосайенсиз, Инк. Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты
US9873907B2 (en) * 2013-05-29 2018-01-23 Agilent Technologies, Inc. Method for fragmenting genomic DNA using CAS9
JP2017513472A (ja) 2014-04-11 2017-06-01 セレクティスCellectis アルギニンおよび/またはトリプトファン枯渇微小環境に対して抵抗性を有する免疫細胞を作製するための方法
US9944933B2 (en) * 2014-07-17 2018-04-17 Georgia Tech Research Corporation Aptamer-guided gene targeting
EP3183358B1 (en) * 2014-08-19 2020-10-07 President and Fellows of Harvard College Rna-guided systems for probing and mapping of nucleic acids
SG11201701245QA (en) 2014-08-27 2017-03-30 Caribou Biosciences Inc Methods for increasing cas9-mediated engineering efficiency
WO2016065364A1 (en) * 2014-10-24 2016-04-28 Life Technologies Corporation Compositions and methods for enhancing homologous recombination
CN104611318B (zh) * 2014-12-18 2017-12-19 北京大学 一种调控核酸酶序列选择性的酶复合物及方法
WO2016130811A1 (en) * 2015-02-11 2016-08-18 Biogen Ma Inc. Methods and compositions for detecting therapeutic nucleic acids
JP2018509148A (ja) 2015-03-11 2018-04-05 セレクティスCellectis 患者における持続性および/または生着を増加させるために同種t細胞を改変する方法
EP3929291A1 (en) * 2015-03-17 2021-12-29 Bio-Rad Laboratories, Inc. Detection of genome editing
US20160289734A1 (en) * 2015-04-03 2016-10-06 University Of Massachusetts Methods of using oligonucleotide-guided argonaute proteins
WO2016166268A1 (en) * 2015-04-17 2016-10-20 Cellectis Engineering animal or plant genome using dna-guided argonaute interference systems (dais) from mesophilic prokaryotes
WO2016201174A2 (en) * 2015-06-10 2016-12-15 Massachusetts Institute Of Technology Gene expression in bacteroides
CN107949400A (zh) * 2015-06-24 2018-04-20 西格马-奥尔德里奇有限责任公司 细胞周期依赖性基因组调控和修饰
JP7033453B2 (ja) 2015-06-30 2022-03-10 セレクティス 特異的エンドヌクレアーゼを使用した遺伝子不活化によってnk細胞の機能性を改善する方法
CN108474007A (zh) 2015-08-07 2018-08-31 联邦科学技术研究组织 产生包含种系遗传修饰的动物的方法
MX387420B (es) 2015-11-24 2025-03-18 Commw Scient Ind Res Org Producción de virus en cultivos celulares.
EP3380616A4 (en) 2015-11-24 2019-11-06 Commonwealth Scientific and Industrial Research Organisation MANUFACTURE OF VIRUSES IN BIRDS
EP3827838B1 (en) 2015-12-16 2023-06-07 The Walter and Eliza Hall Institute of Medical Research Inhibition of cytokine-induced sh2 protein in nk cells
US11746349B2 (en) 2016-02-09 2023-09-05 President And Fellows Of Harvard College DNA-guided gene editing and regulation
DK3455372T3 (da) 2016-05-11 2020-01-06 Illumina Inc Polynukleotidberigelse og -amplifikation ved anvendelse af argonautsystemer
ES2985812T3 (es) 2016-09-09 2024-11-07 The Board Of Trustees Of The Leland Stanfordjunior Univ Edición genómica de precisión de alto rendimiento
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
US20190264218A1 (en) 2016-11-04 2019-08-29 Flagship Pioneering Innovations V, Inc. Novel Plant Cells, Plants, and Seeds
US11261483B2 (en) * 2016-11-09 2022-03-01 Board Of Trustees Of The University Of Illinois Programmable DNA-guided artificial restriction enzymes
CN110546265A (zh) * 2017-02-09 2019-12-06 因达普塔治疗公司 工程化自然杀伤(nk)细胞及其组合物和方法
US20200407737A1 (en) 2017-05-03 2020-12-31 KWS SAAT SE & Co. KGaA Use of crispr-cas endonucleases for plant genome engineering
EP3625340A4 (en) 2017-05-18 2021-02-24 Cargill, Incorporated GENOME EDITING SYSTEM
WO2018217756A1 (en) * 2017-05-24 2018-11-29 Tets Viktor Veniaminovich Oligonucleotide compositions and methods for treating diseases
US11466264B2 (en) 2017-06-28 2022-10-11 New England Biolabs, Inc. In vitro cleavage of DNA using argonaute
CA3067914A1 (en) 2017-06-30 2019-01-03 Cellectis Cellular immunotherapy for repetitive administration
CA3074872A1 (en) * 2017-09-07 2019-03-14 The Board Of Trustees Of The Leland Stanford Junior University Nuclease systems for genetic engineering
EP3679143A1 (en) 2017-09-08 2020-07-15 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
US11926835B1 (en) 2018-01-29 2024-03-12 Inari Agriculture Technology, Inc. Methods for efficient tomato genome editing
WO2019152941A1 (en) 2018-02-05 2019-08-08 Caribou Biosciences, Inc. Engineered gut microbes for reduction of reactivation of detoxified drugs
CN108796036B (zh) * 2018-04-03 2021-11-19 交弘生物科技(上海)有限公司 基于原核Argonaute蛋白的核酸检测方法及其应用
WO2019222036A1 (en) 2018-05-18 2019-11-21 Insideoutbio, Inc. Genetically engineered argonaute proteins with enhanced gene silencing activity and methods of use thereof
EP3884041A2 (en) 2018-11-21 2021-09-29 Indapta Therapeutics, Inc. Methods for expansion of natural killer (nk) cell subset and related compositions and methods
CN109680044B (zh) * 2019-01-21 2021-04-30 北京大学 一种基于选择性消除野生链背景干扰的基因突变检测方法
KR102944320B1 (ko) 2019-03-01 2026-03-25 신젠타 크롭 프로텍션 아게 네이티브 miRNA의 게놈 편집을 통한 표적 유전자 발현의 억제
CA3132374A1 (en) 2019-03-06 2020-09-10 The Board Of Trustees Of The Leland Stanford Junior University Mesophilic argonaute systems and uses thereof
US12016920B2 (en) * 2019-06-06 2024-06-25 Denka Company Limited Adjuvant based on peptide nucleic acid
CN114630910A (zh) 2019-06-25 2022-06-14 伊纳瑞农业技术有限公司 改善的同源依赖修复基因组编辑
WO2021007089A1 (en) * 2019-07-08 2021-01-14 Pillargo, Inc. Homologous recombination directed genome editing in eukaryotes
EP3999103A4 (en) 2019-07-19 2023-11-22 Inari Agriculture Technology, Inc. GENOMIC EDITING FOR ENHANCED HOMOLOGY-DIRECTED REPAIR
US20240011082A1 (en) * 2020-09-08 2024-01-11 The Board Of Trustees Of The University Of Illinois Rapid, accurate, scalable and portable testing (spot) system
US20240312562A1 (en) * 2020-10-26 2024-09-19 Eclipse Bioinnovations, Inc. Methods and kits for enriching for polynucleotides
WO2022125000A1 (en) * 2020-12-08 2022-06-16 Chulalongkorn University A pharmaceutical composition and a method of using the same for suppressing cancer development in a subject
EP4330389A4 (en) * 2021-04-30 2025-04-30 Alnylam Pharmaceuticals, Inc. RISC REORIENTATION FOR RNA EDITING
GB202112807D0 (en) 2021-09-08 2021-10-20 Univ Edinburgh Genetic resistance to viral disease in salmonid fish
WO2024112773A1 (en) * 2022-11-22 2024-05-30 Fc Ip Holdings, Llc Dna editing constructs and methods using the same
GB202307563D0 (en) * 2023-05-19 2023-07-05 Univ King Abdullah Sci & Tech Methods and compositions
WO2025171411A1 (en) 2024-02-09 2025-08-14 Herophilus, Inc. Compositions and methods related to modulating macrophage migration inhibitory factor (mif)-cd74 signaling and related treatments for neuroinflammatory conditions
EP4663200A1 (en) * 2024-06-10 2025-12-17 CPTx GmbH Compositions and methods
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919277B2 (en) 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
DK2341149T3 (da) 2005-08-26 2017-02-27 Dupont Nutrition Biosci Aps Anvendelse af CRISPR-associerede gener (Cas)
DK2426220T3 (da) 2006-05-19 2016-09-26 Dupont Nutrition Biosci Aps Mærkede mikroorganismer og fremgangsmåder til mærkning
WO2007144770A2 (en) 2006-06-16 2007-12-21 Danisco A/S Bacterium
CN101688241B (zh) 2007-03-02 2015-01-21 杜邦营养生物科学有限公司 具有改善的噬菌体抗性的培养物
EP2210104A4 (en) 2007-11-01 2011-02-23 Univ Arizona State CELL-FREE PROCEDURE FOR DETECTING PROTEIN-LIGAND INTERACTIONS
WO2010011961A2 (en) 2008-07-25 2010-01-28 University Of Georgia Research Foundation, Inc. Prokaryotic rnai-like system and methods of use
US9404098B2 (en) 2008-11-06 2016-08-02 University Of Georgia Research Foundation, Inc. Method for cleaving a target RNA using a Cas6 polypeptide
US10662227B2 (en) 2008-11-07 2020-05-26 Dupont Nutrition Biosciences Aps Bifidobacteria CRISPR sequences
WO2010066907A1 (en) 2008-12-12 2010-06-17 Danisco A/S Genetic cluster of strains of streptococcus thermophilus having unique rheological properties for dairy fermentation
EP2292731B1 (en) 2009-08-13 2018-04-04 DuPont Nutrition Biosciences ApS Method for preparing complex cultures
MX2012013037A (es) 2010-05-10 2013-07-29 Univ California Composiciones de endorribonucleasa y metodos de uso de las mismas.
CN103261213A (zh) 2010-10-20 2013-08-21 杜邦营养生物科学有限公司 乳球菌CRISPR-Cas序列
UA115772C2 (uk) 2011-12-16 2017-12-26 Таргітджин Байотекнолоджиз Лтд Композиція програмованого нуклеопротеїнового молекулярного комплексу і спосіб модифікування заданої послідовності нуклеїнової кислоти-мішені
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
RU2662932C2 (ru) 2013-03-14 2018-07-31 Карибо Биосайенсиз, Инк. Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты

Also Published As

Publication number Publication date
US20150089681A1 (en) 2015-03-26
EP2984175A1 (en) 2016-02-17
US10125375B2 (en) 2018-11-13
WO2014189628A1 (en) 2014-11-27
US20180171359A1 (en) 2018-06-21
EP2984175A4 (en) 2016-09-28
US9902973B2 (en) 2018-02-27
HK1220734A1 (en) 2017-05-12
EP2984175B1 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
US10125375B2 (en) Methods of modifying a target nucleic acid with an Argonaute
US20250320490A1 (en) Compositions and methods of nucleic acid-targeting nucleic acids
HK1220734B (en) Dna-guided dna interference by a prokaryotic argonaute
HK40016299B (en) Crispr-cas compositions of nucleic acid-targeting nucleic acids
HK40016299A (en) Crispr-cas compositions of nucleic acid-targeting nucleic acids